[Retracted] Effectiveness of GnRH Antagonists and Agonists in Patients with Hormone-Sensitive Prostate Cancer: A Retrospective Study

Table 1

Baseline data of the included patients before propensity score matching.

Indicators	Antagonist	Agonist	value
Cases ()	52	65
Age (year)			0.547
TNM stage ()			0.225
T1-T2	2	8
T3-T4	10	13
M1	40	44
Gleason score			0.663
≤7 points	15	18
>7 points	37	47
PSA control rate (%)			0.001
With abiraterone	88	62
Without abiraterone	54.28	47.91
Median time to reexamination (day)	36	38	0.590